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Abstract
Background: Norvaline is an unusual non-proteinogenic branched-chain amino acid which has been of interest
especially during the early enzymological studies on regulatory mutants of the branched-chain amino acid pathway
in Serratia marcescens. Only recently norvaline and other modified amino acids of the branched-chain amino acid
synthesis pathway got attention again when they were found to be incorporated in minor amounts in
heterologous proteins with a high leucine or methionine content. Earlier experiments have convincingly shown
that norvaline and norleucine are formed from pyruvate being an alternative substrate of α-isopropylmalate
synthase, however so far norvaline accumulation was not shown to occur in non-recombinant strains of E. coli.
Results: Here we show that oxygen limitation causes norvaline accumulation in E. coli K-12 W3110 during grow
in glucose-based mineral salt medium. Norvaline accumulates immediately after a shift to oxygen limitation at high
glucose concentration. On the contrary free norvaline is not accumulated in E. coli W3110 in aerobic cultures.
The analysis of medium components, supported by transcriptomic studies proposes a purely metabolic overflow
mechanism from pyruvate into the branched chain amino acid synthesis pathway, which is further supported by
the significant accumulation of pyruvate after the oxygen downshift. The results indicate overflow metabolism
from pyruvate as necessary and sufficient, but deregulation of the branched chain amino acid pathway may be an
additional modulating parameter.
Conclusion: Norvaline synthesis has been so far mainly related to an imbalance of the synthesis of the branched
chain amino acids under conditions were pyruvate level is high. Here we show that simply a downshift of oxygen
is sufficient to cause norvaline accumulation at a high glucose concentration as a consequence of the accumulation
of pyruvate and its direct chain elongation over α-ketobutyrate and α-ketovalerate.
Although the flux to norvaline is low, millimolar concentrations are accumulated in the cultivation broth, which 
is far above the level which has been discussed for being relevant for misincorporation of norvaline into 
recombinant proteins. Therefore we believe that our finding is relevant for recombinant protein production but 
also may even have implications for the physiology of E. coli under oxygen limitation in general.
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Background
Norvaline belongs to the group of non-usual amino acid
analogs that may be formed under certain circumstances
as byproducts of the branched-chain amino acid biosyn-
thetic pathway in E. coli and other Gram-negative micro-
organisms. These amino acids can accumulate and are
secreted under certain cultivation conditions.
Historically, norvaline has been reported in one example
to be a natural component of an antifungal peptide pro-
duced by Bacillus subtilis [1]. Later it was found as a side
product in isoleucine overproducing regulatory mutants
of Serratia marcescens which initiated a number of physio-
logical studies by Chibata and colleagues [2-7]. Recently,
the formation of modified branched chain amino acids
has got increasing attention as these amino acids
appeared to be incorporated in certain recombinant pro-
teins produced in E. coli, e.g. β-methylnorleucine into a
recombinant hirudin [8-10], norleucine into recombinant
human brain derived neurotrophic factor [11], inter-
leukin 2 [12-14], and bovine somatotropin [15], and nor-
valine into recombinant hemoglobin [16].
Incorporation of the modified amino acids into proteins
occurs over mis-aminoacylation of tRNAs; namely of leu-
cine-tRNA by norvaline, methionine-tRNA by norleucine
[11-23] and to a low probability by norvaline, and ile-
tRNA by β-methylnorleucine.
The incorporation of these unusual amino acids in recom-
binant proteins has been assigned to conditions which
derepress the branched-chain amino acid pathway, which
can occur due to strong expression of leucine-rich proteins
[14]. Subsequently derepression of the pathway occurs by
the low concentration of the proteinogenic amino acid
leucine.
The synthesis of the modified amino acids of the
branched-chain amino acid synthesis pathway derives
from the isoleucine route which starts with α-ketobutyrate
and their synthesis is caused by the low specificity of the
enzymes of the branched-chain amino acid synthesis
pathway (including the gene products of the ilv and leu
operons) for α-keto acids. A probable scheme of the syn-
thesis of the modified amino acids has been published by
Apostol et al. [16] and is shown for norvaline in Figure 1.
The branched-chain amino acid pathway for the synthesis
of the three amino acids isoleucine, valine and leucine is
closely interconnected to the glycolytic pathway. The
major glycolysis-based metabolic intermediates involved
are pyruvate and acetyl-CoA. α-ketobutyrate which is the
substrate for the isoleucine pathway is synthesized from
oxaloacetate over a number of intermediates, including L-
aspartate, homoserine, and threonine. However, as a
shorter and probable alternative for accumulation of α-
ketobutyrate during conditions where the modified
amino acids accumulate transiently, the direct extension
of the carbon chain of pyruvate by the enzymes of the leu
operon was proposed by Bogosian et al. [15] supported by
kinetic data for α-isopropylmatate synthase from Salmo-
nella typhimurium [24] and Serratia marcescens [2].
The specific feature of the branched amino acid pathway
which has made this route interesting for a number of
molecular-physiological and biochemistry studies is (i)
the interactive metabolic feed-back regulation of synthetic
enzymes by accumulation of one or more of the amino
acids. In consequence amino acid starvation responses
can be provoked by over-accumulation of one of the
amino acids, which leads to suppression of the synthesis
of the others. A well established example is the induction
of the stringent response in E. coli K-12 strains by addition
of valine which results in isoleucine starvation [25,26].
(ii) The expression levels of the enzymes of the branched-
chain amino acid pathway are regulated in dependence
on the cellular concentration of each of the branched
chain amino acids by the interactive repression of mRNA
synthesis of the operons of the metabolic pathway by
attenuation. (iii) Finally, a specific characteristic of the
enzymes of this pathway is their low substrate specificity.
Most of the enzymes can accept other than the main α-
ketoacids as substrate. As a result, also other modified
amino acids can be synthesized. Norvaline and norleu-
cine directly diverge from α-ketobutyrate by chain elonga-
tion through the action of α-isopropylmalate synthase (α-
IPMS),  α-isoprolylmalate isomerase, β-isoprolylmalate
dehydrogenase and following transamination. For this
reaction accumulation of α-ketobutyrate is a prerequisite,
because the affinity of α-IPMS for α-ketobutyrate is an
order of magnitude higher compared to its natural sub-
strate α-ketoisovalerate [2] as detected for S. marcescens.
No enzymatic data are available to our knowledge for the
corresponding E. coli enzymes.
This possibility of the enzymes encoded by the leuABCD
operon to use other substrates suggests a direct possibility
for chain elongation from pyruvate (3C) over α-ketobu-
tyrate (4C) and α-ketovalerate (5C) to α-ketocaproate
(6C). This hypothesis is further supported by experimen-
tal data from Apostol et al. [16]. In their study the first
response to hemoglobin induction is a decrease of the leu-
cine pool and the accumulation of pyruvate, which results
in the immediate increase of norvaline, followed by a later
accumulation of norleucine.
In the actual study we show by metabolic shift experi-
ments that norvaline is not accumulated in wild type E.
coli K-12 strains during aerobic cultivation on mineral salt
medium, but only after a switch from aerobic to anaerobicMicrobial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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conditions at a high glucose concentration. Our results
support the model proposing that pyruvate is directly con-
verted to α-ketobutyrate, which indicates that also condi-
tions which lead to accumulation of pyruvate by natural
responses may cause norvaline synthesis. The results also
provide evidence that norvaline synthesis after an oxygen
downshift is not related to induction or derepression of
the enzymes of the branched chain amino acids, but
rather to a metabolic overflow reaction.
Results
Earlier it has been suggested that norvaline synthesis may
be triggered by conditions which lead to accumulation of
pyruvate [16]. It is well known that pyruvate strongly
increases in E. coli during unlimited growth on glucose if
the environment is shifted from aerobic to anaerobic con-
ditions. However, it has not been tested so far whether
such a shift also stimulates norvaline synthesis.
As the norvaline level in aerobically grown cells is below
the detection limit (Fig. 2A) and difficult to analyze at low
cell densities (own unpublished results), we performed
cultivations at high cell densities. Therefore E. coli W3110
was cultivated on mineral salt medium with an initial glu-
cose concentration of 40 g L-1. The culture was grown up
to an OD600 of about 40 (about 15 g L-1 cell dry weight)
when oxygen limitation was initiated by a step-decrease of
the agitation rate, resulting in a lower oxygen transfer rate
Schematic view of the branched chain amino acid pathway with the proposed pathway for norvaline synthesis from pyruvate in  relation with glycolysis and the tricarbonic acid cycle in E. coli Figure 1
Schematic view of the branched chain amino acid pathway with the proposed pathway for norvaline synthesis 
from pyruvate in relation with glycolysis and the tricarbonic acid cycle in E. coli. Overflow metabolites and anaero-
bic routes are included. For simplification some metabolic pathways with more steps are illustrated by an interrupted line. 
Numbers relate to the amount of enzymatic reactions. Enzymes are indicated by their gene names.
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HPLC chromatogram of crude extracts (containing cells and medium) from E. coli W3110 cultivations in glucose containing  mineral salt medium Figure 2
HPLC chromatogram of crude extracts (containing cells and medium) from E. coli W3110 cultivations in glu-
cose containing mineral salt medium. Samples were harvested 10 h after an oxygen downshift (B) or during an aerobic 
batch culture (A) grown.Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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and consequently the dissolved oxygen tension (DOT)
decreased immediately to zero. The amount of glucose
was kept non-limiting by constant feeding of a highly con-
centrated glucose solution in a fed-batch mode. As a con-
trol an aerobic cultivation was performed in the same
way, however with a glucose-limited feeding to avoid oxy-
gen limitation. As is seen from figure 3, the typical anaer-
obic metabolites of the mixed acid fermentation of E. coli
accumulate after the downshift of the stirrer rate including
acetate, formate, succinate, lactate, and ethanol indicating
that the culture responds by anaerobic metabolism
despite the continuous supply of air.
As expected, aside from a decrease of the cell growth, the
anaerobic shift also caused accumulation of pyruvate.
Pyruvate is a central metabolic compound for many path-
ways. Therefore one might hypothesisze that such a signif-
icant accumulation of pyruvate affects not only the flow
into the typical anaerobic metabolic pathways but also
into the pyruvate-connected routes for amino acid synthe-
sis. To investigate this, we analyzed the concentrations of
free amino acids in both cultivation types, with a down-
shift of the stirrer rate and without (Fig. 4). Interestingly,
in agreement with our hypothesis we detected a signifi-
cant increase in certain amino acids after the switch to
anaerobic growth conditions especially in pathways
which are closely connected to pyruvate, such as alanine,
valine, and somewhat less significantly for leucine. Also
glutamine and aspartate showed a significant increase,
and asparagine increased with a similar kinetics as aspar-
tate, but the concentration remained three orders of mag-
nitude lower (μM range). In contrast isoleucine did not
increase (see Fig. 4), and similarly most of the other
High cell density cultures of E. coli W3110 without (A, C) and with a stirrer downshift resulting in oxygen limited culture (B, D) Figure 3
High cell density cultures of E. coli W3110 without (A, C) and with a stirrer downshift resulting in oxygen lim-
ited culture (B, D). The graphs show the data for cell dry weight (g L-1), dissolved oxygen tension (DOT), glucose concen-
tration (A, B) and the anaerobic metabolites acetate, lactate, formate, ethanol, succinate (C, D, symbols shown in C). 
Anaerobic conditions in graphs (B, D) were caused by a downshift of the stirrer speed whereas the aeration rate was kept con-
stant, as described in the Material and Methods section. The glucose feed was started at 0 hours. The stirrer downshift was 
performed at -10 min.Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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Concentrations of free amino acids and pyruvate during fed-batch cultivations of E. coli W3110 without (as control, open  squares) and with a stirrer downshift resulting in an oxygen limited culture (closed triangles) Figure 4
Concentrations of free amino acids and pyruvate during fed-batch cultivations of E. coli W3110 without (as 
control, open squares) and with a stirrer downshift resulting in an oxygen limited culture (closed triangles). 
The analysis was performed from clarified crude extracts containing medium and cells as described in Materials and Methods.Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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amino acids, which are not directly related to pyruvate,
did not increase in their concentrations (not shown).
Interestingly, a distinct norvaline peak was detected in
HPLC chromatograms of the anaerobic culture which was
not found in aerobic control cultures (see Fig. 2). Norva-
line increased significantly and accumulated to about 1
mM at 7 hours after the stirrer downshift. This was the
highest concentration of a branched chain amino acid
detected during the cultivation with the stirrer downshift.
In contrast, the norvaline remained below the detection
limit in all samples from the aerobic control fermentation
(see Fig. 4).
Next, it was interesting to investigate whether norvaline
accumulation occurs simply due to the accumulation of
pyruvate, or whether additionally a deregulation of the
synthesis of enzymes of the branched chain amino acid
pathway is needed. Therefore, we studied the transcrip-
tional profile of a number of marker genes during the shift
to anaerobiosis (Figs. 5 and 6). The transcriptional pro-
files showed a clear induction of anaerobic metabolism by
the stirrer downshift. The most significant event was the
induction of pyruvate formate lyase (pflB), which
responded immediately after the DOT dropped to zero,
and interestingly even responded very sensitively to small
changes in the process. For example, the pflB mRNA level
immediately decreased when the culture run into glucose
starvation for a short time at about 15 min after the anaer-
obic shift and it increased immediately after the DOT
decreased to zero again (Fig. 5). Also the expression of lac-
tate dehydrogenase (ldhA) behaved similarly. Also DNA-
microarray analysis indicated a significant induction of
the genes of anaerobic metabolism, such as the FNR regu-
lon and the operons of formate dehydrogenase (fdh) and
formate hydrogen lyase (hyc) which are included in for-
mate degradation, already 20 min after the down-shift
(Fig. 6). It should be remarked, however, that the pflB sig-
nal from the microarrays was different. In the DNA micro-
arrays no induction of pflB  was detected, which is
remarkable as it contradicts the results with the sandwich
hybridization assay and the finding that formate accumu-
lated significantly.
A typical anaerobic reaction was the strong repression of
the aceE and aceF mRNAs encoding polypeptides of the
pyruvate dehydrogenase complex as observed by microar-
ray analysis (not shown, see additional material). All
other genes of the glycolysis were only marginally down-
regulated. Also the genes of the tricarbonic acid cycle
reacted in a typical way [27,28] (see Fig. 6), the mRNAs of
the suc and sdh operons decreased very strongly. A signifi-
cant decrease was also observed for the icdA mRNA encod-
ing for isocitrate dehydrogenase, mdh mRNA encoding for
malate dehydrogenase, and fumA encoding for the aerobic
fumarate hydratase. A strong increase was seen for the
mRNAs of enzymes of the left branch of TCA responsible
for the reactions from oxaloacetate to succinate, such as
fumB encoding the anaerobic fumarate hydratase and the
frd operon encoding subunits of the fumarate reductase.
The mRNA of citrate synthase (gltA) was slightly repressed
and recovered later according to the DNA array data (Fig.
6a) and similar also in the sandwich hybridization (Fig.
5), although here the gltA level decreased below the detec-
tion limit, but showed a high expression in the last sam-
ple.
The data for the mRNAs of the branched chain amino acid
pathway from the DNA arrays showed generally a
decrease of all of the mRNAs after the oxygen downshift
with a fast initial response between the samples collected
20 min before the oxygen downshift and 10 min after it
(Fig. 6e). A more detailed dynamic response was obtained
by analysis of some representative mRNAs from the differ-
ent operons by sandwich hybridization. Interestingly, but
not unexpected, this showed a fast and transient accumu-
lation of the ilvA  mRNA after the anaerobic shift.
Although the increase was only approximately two-fold,
the curve showed a similar shape as for pflB (Fig. 5). All
other mRNAs of the pathway were not observed to react so
clearly and fast to oxygen depletion. However, there was a
second slower continuous increase of the mRNA levels of
ilvA, leuA, and ilvG after 1.5 hours. In contrast, there was
no significant derepression observed for the level of the
ilvB and ilvI mRNAs coding of the large subunits of aceto-
hydroxy acid synthetases (AHAS) I and III respectively.
These data suggest that it is unlikely that the synthesis of
norvaline is due to an extra derepression of the leucine
operon, but that the existing enzymes account for the syn-
thesis. This was further confirmed by 2-dimensional elec-
trophoresis of the proteome which indicated no
significant increase of any of the enzymes of the branched
chain amino acid synthetic pathway after the anaerobic
shift (data not shown).
Discussion
The results presented here show that E. coli W3110 is able
to produce the amino acid analogue norvaline after a shift
from aerobic to anaerobic conditions in a culture on pure
glucose mineral salt medium. This is new and interesting,
as so far norvaline accumulation has been described only
for mutant strains, e.g. for mutants of Serratia marcescens
which are used for isoleucine production [5,7], and for
recombinant E. coli strains which express of recombinant
proteins with a high content of leucine and which conse-
quently decrease the cellular leucine pool [16]. It is sur-
prising that norvaline is produced by a normal
environmental shift. The conditions which have been
shown here to result in norvaline accumulation are rele-Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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Dynamic response of the mRNAs of a number of mRNAs after the stirrer downshift during cultivation of E. coli W3110 Figure 5
Dynamic response of the mRNAs of a number of mRNAs after the stirrer downshift during cultivation of E. coli 
W3110. The mRNA levels were analyzed by bead-based sandwich hybridization and quantified by use of in vitro standards.Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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vant when shake flask cultures run into oxygen limitation.
Also large- scale processes which are characterized by
imperfect mixing may result in norvaline accumulation,
as it is known that high glucose concentration and oxygen
limitation characterize feeding zones of large-scale biore-
actors [29]. Although there is no specific cellular function
known for norvaline in E. coli, it has been shown that nor-
valine can be incorporated in recombinant proteins
instead of leucine, which is generally not wanted.
Pyruvate is a starting metabolite for the branched chain
amino acid pathway and the synthesis of the amino acid
analog norvaline from α-ketobutyrate. There is strong evi-
dence that the synthesis of norvaline or norleucine is due
to direct chain elongation of pyruvate over 2-ketobutyrate
and 2-ketocaproate (for norleucine) if the derepression of
the leucine operon is caused by depletion of the amino
acid leucine through strong induction of recombinant
proteins with an over-average content of leucine [15,16].
In the case of our experimental set-up the leucine concen-
tration was low due to cultivation on mineral salt medium
and correspondingly the leucine operon was derepressed
as is seen by the level of α-IPMS mRNA confirming the
results by Bogosian et al. [15].
The critical factor in our experiments was the accumula-
tion of pyruvate, caused by down-shifts of the oxygen
level. Pyruvate accumulation and norvaline incorporation
into a recombinant product has been observed by Apostol
et al. [16] in aerobic conditions. Although the authors did
not discuss the origin of this increase, it seems that the
high pyruvate concentration in their cultivation resulted
from changes in metabolic fluxes through the glycolysis
due to expression of their recombinant product. Uncou-
pling of the glycolysis and respiration after strong induc-
tion of recombinant product have been observed earlier
[30], but have not been attributed to fluxes in the amino
acid pathways.
As the high pyruvate concentration in crude broth lysates
and a derepression of the leucine operon were fulfilled in
our experiments, we believe that norvaline accumulation
occurred by chain elongation of pyruvate. Although a
detailed metabolic flux analysis is needed for validation,
this hypothesis is strongly supported by the high concen-
tration of pyruvate, which is two orders of magnitude
above the concentration of threonine and significantly
above the apparent Km of the α-isopropylmalate synthase
for pyruvate (10 mM, [24]). The direct chain elongation
by the enzymes of the leuABCD operon is more likely
than assuming the flux going over the long oxaloacetate
and threonine pathway.
DNA microarray data on the dynamic change of the mRNAs of key enzymes of the tricarbonic acid cycle (A-C), anaerobic  metabolism (D), and the branched chain amino acid pathway (E, F) during cultivation of E. coli W3110 with a stirrer downshift  to cause anaerobic conditions Figure 6
DNA microarray data on the dynamic change of the mRNAs of key enzymes of the tricarbonic acid cycle (A-
C), anaerobic metabolism (D), and the branched chain amino acid pathway (E, F) during cultivation of E. coli 
W3110 with a stirrer downshift to cause anaerobic conditions.Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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It may be remarked, that we also found an accumulation
of aspartate and principally there should be the option
that α-ketobutyrate is synthesized over the aspartate-thre-
onine pathway. Interesting in this view is the anaerobic
positive regulation of ilvA. IlvA mRNA was clearly shown
to accumulate by measuring the dynamic response by
sandwich hybridization although this response was not
seen in the DNA array analysis, which only covered the
first hour after the anaerobic shift with 3 samples col-
lected in 30 min time space. However, despite the dere-
pression of gene expression during anaerobic growth as
monitored on the mRNA level (Fig. 5) and by protein syn-
thesis (35S-methionine labeling of proteome and 2D elec-
trophoresis, not shown) the amount of threonine
deaminase was not significantly increasing (2D electro-
phoresis, not shown). Also, the level of threonine did not
increase, which might be eventually expected if the flux
through this pathway should be high. Therefore, we con-
clude that norvaline is produced by direct chain elonga-
tion of pyruvate as described before in recombinant
processes.
Norvaline accumulation was only observed when we
shifted the cells from aerobic to anaerobic conditions
abruptly at a high glucose concentration. No norvaline
accumulation was found when the aeration was shut off
in a glucose limited chemostat and the glucose concentra-
tion increased gradually (data not shown), or when glu-
cose limited cells in a chemostat growing with a specific
growth rate of 0.1 h-1 obtained a glucose pulse. Similar
chemostat experiments performed by Chassagnole et al.
[31] showed that the cellular pyruvate level only increased
to about 4 mM, which is far below the level which was e.g.
detected by [16] and in our studies. Long term cultivation
under lower growth rate decreases the glucose uptake
capacity [32] and although experimental data are not
available to our knowledge, it could be proposed that the
lower influx of glucose in a culture growing with a low
specific growth rate may negatively affect the accumula-
tion of pyruvate. Therefore we see the chemostat data in
agreement with the assumption that a high glucose flux
into the glycolysis is an important parameter.
Finally, we want to highlight the fact that the accumula-
tion of norvaline might be favored in E. coli K-12 strains
by the frameshift mutation in the ilvG gene, an interesting
point, which is currently under investigation.
Conclusion
In this study we have shown that norvaline can accumu-
late in the well-known E. coli K-12 strain W3110 if it is
grown in mineral salt medium under conditions where
fast growing cells undergo a shift to anaerobiosis. The
important parameters seem to be a high expression of the
enzymes of the leucine operon and the accumulation of
pyruvate. It is likely that pyruvate is the substrate for direct
keto chain elongation to α-ketobutyrate and further to α-
ketovalerate from which norvaline is synthesized by
transamination. The level of accumulated norvaline is
very high. It remains to be investigated whether this might
have relevance for the cell physiology. So far in most pro-
teins where norvaline was incorporated the activity of the
protein was maintained. The new mechanism of norva-
line might be of direct biotechnological relevance if one
aims to incorporate norvaline into proteins, e.g. for struc-
tural studies.
Our finding also may be of practical relevance for securing
the production of non-modified recombinant proteins.
The oxygen level e.g. in a shake flask culture or the occur-
rence of oxygen starvation zones in a large-scale bioreac-
tor may have an impact on the appearance and
incorporation of norvaline.
Methods
Strain and cultivation conditions
The strain used in this study was E. coli W3110 [F-
IN(rrnD-rrnE)1].
The cultivations were performed in a Biostat C 15 L biore-
actor with the DCU-3 controlling unit and MFCS-win
supervisory system (Sartorius) with an initial working vol-
ume of 8 L. The mineral salt medium contained per liter:
14.6 g K2HPO4, 3.6 g NaH2PO4 × 2 H2O, 2.0 g Na2SO4,
2.47 g (NH4)2SO4, 0.5 g NH4Cl, 1.0 g (NH4)2-H-citrate, 2
mM MgSO4, 0.1 g thiamine hydrochloride, 0.1 mL anti-
foam 204 (Sigma) and 2 mL trace element solution [33].
The initial glucose concentration was 40 g L-1. The feed
solution contained 650 g L-1 glucose. 2 mL L-1 of sterile fil-
tered 1 M MgSO4 were added regularly per OD600 = 10
increase.
Two precultures were performed in LB medium and min-
eral salt medium with 10 g L-1 of glucose without anti-
foam agent consecutively at 37°C at a rotary shaker at 180
rpm. Main cultivations were started as batch cultures at a
temperature of 37°C. The pH was kept at 7.0 by control-
led addition of 25% ammonia solution. At the end of the
exponential growth phase (cell dry weight about 16 g L-1)
the stirrer rate was lowered from 1000 rpm to 500 rpm, to
provoke oxygen limitation by decreased oxygen transfer.
Constant glucose feed of 100 g L-1 h-1 was started 15 min
after the oxygen drop which was enough to ensure glucose
excess during the whole cultivation.
Analysis of cell growth
Cell growth was monitored by measurement of the
absorbance (OD600) and cell dry weight as described ear-
lier [34]. One unit of OD600 corresponds to a dry cell
weight of 0.44 g L-1.Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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Table 1: Primer and probe sequences used in this study.
Probe name Sequence (5'-3') Position/Modification
ilvA
Forward primer TGTCGTCGCGTCTTGATAAC 119
Reverse primer TTCGTCGTGGCAATCGTAGC 1506c
Helper probe 1 GGAAGGTTTCGTCACCGATG 757c
Detection probe GTCGAGATACTCCTGGCATA 780c [3' DIG tail]
Capture probe TCGCTATCGACGGTGATGAT 803c [5' biotin]
Helper probe 2 TCCTTCATCGCCGCACAGAT 827c
ilvG
Forward primer ACTTGCTATGCCGACATGAG 122
Reverse primer GGCCAGACGTTCTCAAGTTC 1593c
Helper probe 1 CCAGAAAGCTGTGCTTGGTA 382c
Detection probe CAACTCTTCCAGCGATGCA 402c [3' DIG tail]
Capture probe AATGCTTCAGCCATGATGCG 425c [5' biotin]
Helper probe 2 ACGACCTGAGCAGGCAACGT 447c
leuA
Forward primer CACATTGCGCGACGGTGAAC 30
Reverse primer CTGCGGCACGCCAGATATTG 1510c
Helper probe 1 TGCTTACCGATGAAGGCCAG 1151c
Detection probe AATGCTCCGGCTCTTCTTGC 1171c [3' DIG tail]
Capture probe CGCTGAAGTAATCCAGATGG 1192c [5' biotin]
Helper probe 2 ATCGTTAGAGCCAGACTGCA 1212c
ilvB
Forward primer GCGGTTCTATGCTGCCTGTT 107
Reverse primer GCGGATCGGCTTCGTTATTC 1561c
Helper probe 1 GCGTTGATCAGGCCGTAA 1127c
Detection probe TCATCGACACAGGCGGCAA 1148c [3' DIG tail]
Capture probe CGTCGGTGGTGATAATTGCA 1171c [5' biotin]
Helper probe 2 TCCACATCTGATGCTGACCA 1192c
ilvI
Forward primer TTGTCTGGAGCCGAGATGGT 10
Reverse primer CATGTCCTGCCACTGCTTCA 1461c
Helper probe 1 TTGTTCGAGGACCTGGC 990c
Detection probe GCGGATTCTTGCGACAAG 1019c [3' DIG tail]
Capture probe CTCATCCAGTGGTTGATG 1038c [5' biotin]
Helper probe 2 TTGCTGCCACCAGTC 1059c
pflB
Forward primer TTCCTGGCTGGCGCTACTGA 128
Reverse primer TCCATCGCGTCGAGCAGCAT 2162c
Helper probe 1 AGGTAGCCGAAGTAAGTCCA 791c
Detection probe TCTGAGACTTAACAGCAGCC 811c [3' DIG tail]
Capture probe CGAAGGACATTGCAGCACCG 832c [5' biotin]
Helper probe 2 CAGGAAGGTGGAGGTACGAC 852c
ldhA
Forward primer CTGCAACAGGTGAACGAGTC 46
Reverse primer CTGGATCACGTCGTTGGATT 831c
Helper probe 1 GGCTGGAACACGGACTACTT 297c
Detection probe CATCATACCGATGGCGTGTT 339c [3' DIG tail]
Capture probe GCAACGGCCTCTGGATCATA 317c [5' biotin]
Helper probe 2 AATACGGCGGTTCAGCGTCA 360c
aceA
Forward primer CATACAGTGCGGAAGATGTG 77
Reverse primer GAACTGCGATTCTTCAGTGG 1302c
Helper probe 1 ACCACAGCTGGCACCGAGTT 362c
Detection probe ACCATTGGATCTGATCGGCA 409c [3' DIG tail]
Capture probe ACGGAAGGTGTTGTTGATCC 387c [5' biotin]
frdA
Forward primer GCCGATCTTGCCATTGTAGG 16
Reverse primer TGGCGGCAGCGTAGTAATCT 1728c
Helper probe 1 TTCATTGCTACCAGGCCGCG 524c
Detection probe CCAGCGTGCCTTCCATCATG 544c [3' DIG tail]Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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Amino acid analysis
The amino acids were analyzed from clarified crude broth
lysates. Therefore broth samples, containing medium and
cells, were taken and immediately shock-frozen in liquid
nitrogen and stored at -20°C until the sample prepara-
tion. Samples, diluted to same cell density with 0.9%
NaCl solution, were sonicated on ice for 2 × 30 sec with
30 sec cooling break between the sonication steps. After
sonication the cell debris was removed by centrifugation
for 10 min (+4°C, 16,100 × g) and the supernatant was
purified from macromolecules by centrifugation for 60
min at 14,000 × g and +4°C using Microcon 3 kDa cut-off
membranes (Millipore). The filtrate was diluted 20 times
with 0.1 M HCl and OPA – precolumn derivatisation was
used for the amino acid analysis. OPA reagent (Agilent)
was diluted 5 times in 0.4 M borate buffer (Agilent) and
equal amounts of diluted sample and OPA reagent were
mixed for reaction. After approximately 1 min 20 μL of
derivatisation reaction solution was injected into the Zor-
bax Eclipse column (Agilent). The inorganic eluent con-
tained 0.03 M sodium acetate, 0.25% tetrahydrofurane (v/
v) and 100 ppm sodium azide, and the pH was set to 7.2
with 1% acetic acid [v/v]. The organic eluent consisted of
80% acetonitrile and 20% of 0.03 M sodium acetate [v/v].
The HPLC equipment consisted of pump series (P580),
autosampler (ASI-100), column oven (HTS-585) and flu-
orescence detector (RF-2000) from Dionex.
Analysis of metabolites and glucose
Acetate, pyruvate, formate, succinate, lactate, ethanol, and
glucose were analyzed from medium samples, which were
immediately centrifuged for 3 min at 16,100× g and
+4°C. The supernatant was filtered (0.2 μm) and frozen in
liquid nitrogen. Pyruvate was analyzed from clarified
crude extracts which were prepared as described for amino
acid analysis. The metabolites were analyzed in a Merck-
Hitachi HPLC system (Model D-7000) with an ICSep
COREGEL 87H3 column. An L-4259 UV-VIS detector
(Merck-Hitachi) at 210 nm was used for the organic acids
and a differential refractometer RI-71 (Merck) for glucose
and ethanol.
mRNA analysis by sandwich hybridization
Samples for mRNA analysis were collected as described
earlier [34]. Samples were shortly mixed by vortexing,
divided in 0.5 mL aliquots and centrifuged for 3 min at
16,100 × g and +4°C. The pellets were resuspended in 250
μL of RNALater (Ambion, USA) and stored at -20°C until
analysis. RNA was extracted using the total RNA kit (A&A
Biotechnology, Poland) following the instructions of the
kit. A sandwich hybridisation assay was performed as
described earlier [35]. In vitro transcribed RNA molecules
were used as standards for quantification of mRNA mole-
cules in the samples (see table 1 for the primers used). The
amplification of in vitro RNA was done as described earlier
(28). For each gene of interest a detection probe labeled
with digoxigenin (Roche, USA), a capture probe labeled
by biotin (by probe manufacturer), and two unlabelled
helper probes were designed. Different sets of probes were
tested and the set producing the highest signal in the sand-
wich assay was chosen (see Table 1 for details of the
probes).
Capture probe CGCGTTAGCACGGATCTGCA 564c [5' biotin]
Helper probe 2 CCGCCAGTAGCCATAACGAC 584c
pykF
Forward primer GAATCTGCGCAACGTGATGA 144
Reverse primer TGTTAGTAGTGCCGCTCGGT 1390c
Helper probe 1 CCTTCATACGTTACCGCAAC 335c
Detection probe GCCAACAGACAGGTCAGTAG 360c [3' DIG tail]
Capture probe GATCAGACCATCGTCAACCA 390c [5' biotin]
Helper probe 2 CTTCAATGGCGGTAACTTCC 415c
ppc
Forward primer GCGCTGGCAATGATGCTAAC 137
Reverse primer CTCGGCCTGCAATACGTTCA 2535c
Helper probe 1 CCTGGCAGGTATCGAGCACT 1378c
Detection probe ATGGAGCCTTGCGGTGCTTC 1433c [3' DIG tail]
Capture probe TTCGCCATCGAGATCACGTA 1406c [5' biotin]
Helper probe 2 TGGACAGCCAGTACGTCGGA 1460c
gltA
Forward primer CTTCACTTCAACCGCATCCT 138
Reverse primer GGCAATCTTCATACCGTCAC 1221c
Helper probe CCATAGCACGTTCCAGAATC 661c
Detection probe GGTAGAGGCGTTCTGTTCAT 708c [3' DIG tail]
Capture probe GTGCAGGATCAGAATACGGT 681c [5' Biotin]
The T7-promoter sequence CTAATACGACTCACTATAGGGAGA was added in the 5'-end of each forward primer.
Table 1: Primer and probe sequences used in this study. (Continued)Microbial Cell Factories 2008, 7:30 http://www.microbialcellfactories.com/content/7/1/30
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Microarray analysis
Experimental procedures for GeneChip (Affymetrix, Santa
Clara, CA, USA) were performed according to the Affyme-
trix GeneChip Expression Analysis Technical Manual.
Affymetrix E. coli Genome 2.0 array was used. Sample
preparation was equal to mRNA analysis by sandwich
hybridization described in previous chapter.
The microarray data have been deposited in NCBI's Gene
Expression Omnibus [36] and are accessible through GEO
Series accession number GSE12006 http://www.ncbi.nlm
.nih.gov/geo/query/acc.cgi?acc=GSE12006.
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